150 related articles for article (PubMed ID: 38421253)
1. Salvage Therapy for Prostate Cancer: AUA/ASTRO/SUO Guideline Part I: Introduction and Treatment Decision-Making at the Time of Suspected Biochemical Recurrence after Radical Prostatectomy.
Morgan TM; Boorjian SA; Buyyounouski MK; Chapin BF; Chen DYT; Cheng HH; Chou R; Jacene HA; Kamran SC; Kim SK; Kirkby E; Luckenbaugh AN; Nathanson BJ; Nyame YA; Posadas EM; Tran PT; Chen RC
J Urol; 2024 Apr; 211(4):509-517. PubMed ID: 38421253
[TBL] [Abstract][Full Text] [Related]
2. Salvage Therapy for Prostate Cancer: AUA/ASTRO/SUO Guideline Part II: Treatment Delivery for Non-metastatic Biochemical Recurrence After Primary Radical Prostatectomy.
Morgan TM; Boorjian SA; Buyyounouski MK; Chapin BF; Chen DYT; Cheng HH; Chou R; Jacene HA; Kamran SC; Kim SK; Kirkby E; Luckenbaugh AN; Nathanson BJ; Nyame YA; Posadas EM; Tran PT; Chen RC
J Urol; 2024 Apr; 211(4):518-525. PubMed ID: 38421243
[TBL] [Abstract][Full Text] [Related]
3. Salvage Therapy for Prostate Cancer: AUA/ASTRO/SUO Guideline Part III: Salvage Therapy After Radiotherapy or Focal Therapy, Pelvic Nodal Recurrence and Oligometastasis, and Future Directions.
Morgan TM; Boorjian SA; Buyyounouski MK; Chapin BF; Chen DYT; Cheng HH; Chou R; Jacene HA; Kamran SC; Kim SK; Kirkby E; Luckenbaugh AN; Nathanson BJ; Nyame YA; Posadas EM; Tran PT; Chen RC
J Urol; 2024 Apr; 211(4):526-532. PubMed ID: 38421252
[TBL] [Abstract][Full Text] [Related]
4. Advanced Prostate Cancer: AUA/ASTRO/SUO Guideline PART I.
Lowrance WT; Breau RH; Chou R; Chapin BF; Crispino T; Dreicer R; Jarrard DF; Kibel AS; Morgan TM; Morgans AK; Oh WK; Resnick MJ; Zietman AL; Cookson MS
J Urol; 2021 Jan; 205(1):14-21. PubMed ID: 32960679
[TBL] [Abstract][Full Text] [Related]
5. Clinically Localized Prostate Cancer: AUA/ASTRO Guideline. Part III: Principles of Radiation and Future Directions.
Eastham JA; Auffenberg GB; Barocas DA; Chou R; Crispino T; Davis JW; Eggener S; Horwitz EM; Kane CJ; Kirkby E; Lin DW; McBride SM; Morgans AK; Pierorazio PM; Rodrigues G; Wong WW; Boorjian SA
J Urol; 2022 Jul; 208(1):26-33. PubMed ID: 35536141
[TBL] [Abstract][Full Text] [Related]
6. Clinically Localized Prostate Cancer: AUA/ASTRO Guideline, Part I: Introduction, Risk Assessment, Staging, and Risk-Based Management.
Eastham JA; Auffenberg GB; Barocas DA; Chou R; Crispino T; Davis JW; Eggener S; Horwitz EM; Kane CJ; Kirkby E; Lin DW; McBride SM; Morgans AK; Pierorazio PM; Rodrigues G; Wong WW; Boorjian SA
J Urol; 2022 Jul; 208(1):10-18. PubMed ID: 35536144
[TBL] [Abstract][Full Text] [Related]
7. Adjuvant and salvage radiotherapy after prostatectomy: AUA/ASTRO Guideline.
Thompson IM; Valicenti RK; Albertsen P; Davis BJ; Goldenberg SL; Hahn C; Klein E; Michalski J; Roach M; Sartor O; Wolf JS; Faraday MM
J Urol; 2013 Aug; 190(2):441-9. PubMed ID: 23707439
[TBL] [Abstract][Full Text] [Related]
8. Advanced Prostate Cancer: AUA/ASTRO/SUO Guideline PART II.
Lowrance WT; Breau RH; Chou R; Chapin BF; Crispino T; Dreicer R; Jarrard DF; Kibel AS; Morgan TM; Morgans AK; Oh WK; Resnick MJ; Zietman AL; Cookson MS
J Urol; 2021 Jan; 205(1):22-29. PubMed ID: 32960678
[TBL] [Abstract][Full Text] [Related]
9. Clinically Localized Prostate Cancer: AUA/ASTRO Guideline, Part II: Principles of Active Surveillance, Principles of Surgery, and Follow-Up.
Eastham JA; Auffenberg GB; Barocas DA; Chou R; Crispino T; Davis JW; Eggener S; Horwitz EM; Kane CJ; Kirkby E; Lin DW; McBride SM; Morgans AK; Pierorazio PM; Rodrigues G; Wong WW; Boorjian SA
J Urol; 2022 Jul; 208(1):19-25. PubMed ID: 35536148
[TBL] [Abstract][Full Text] [Related]
10. Early Detection of Prostate Cancer: AUA/SUO Guideline Part II: Considerations for a Prostate Biopsy.
Wei JT; Barocas D; Carlsson S; Coakley F; Eggener S; Etzioni R; Fine SW; Han M; Kim SK; Kirkby E; Konety BR; Miner M; Moses K; Nissenberg MG; Pinto PA; Salami SS; Souter L; Thompson IM; Lin DW
J Urol; 2023 Jul; 210(1):54-63. PubMed ID: 37096575
[TBL] [Abstract][Full Text] [Related]
11. Salvage Surgery in Patients with Local Recurrence After Radical Prostatectomy.
Knipper S; Ascalone L; Ziegler B; Hohenhorst JL; Simon R; Berliner C; van Leeuwen FWB; van der Poel H; Giesel F; Graefen M; Eiber M; Heck MM; Horn T; Maurer T
Eur Urol; 2021 Apr; 79(4):537-544. PubMed ID: 33317857
[TBL] [Abstract][Full Text] [Related]
12. Post-prostatectomy radiation therapy for locally recurrent prostate cancer.
Isharwal S; Stephenson AJ
Expert Rev Anticancer Ther; 2017 Nov; 17(11):1003-1012. PubMed ID: 28922958
[TBL] [Abstract][Full Text] [Related]
13. Prediction of outcome following early salvage radiotherapy among patients with biochemical recurrence after radical prostatectomy.
Briganti A; Karnes RJ; Joniau S; Boorjian SA; Cozzarini C; Gandaglia G; Hinkelbein W; Haustermans K; Tombal B; Shariat S; Sun M; Karakiewicz PI; Montorsi F; Van Poppel H; Wiegel T
Eur Urol; 2014 Sep; 66(3):479-86. PubMed ID: 24345725
[TBL] [Abstract][Full Text] [Related]
14. Phase III randomised controlled trial on PSMA PET/CT guided hypofractionated salvage prostate bed radiotherapy of biochemical failure after radical prostatectomy for prostate cancer (PERYTON-trial): study protocol.
Staal FHE; Janssen J; Brouwer CL; Langendijk JA; Ng Wei Siang K; Schuit E; de Jong IJ; Verzijlbergen JF; Smeenk RJ; Aluwini S
BMC Cancer; 2022 Apr; 22(1):416. PubMed ID: 35428210
[TBL] [Abstract][Full Text] [Related]
15. Contemporary role of salvage lymphadenectomy in patients with recurrence following radical prostatectomy.
Abdollah F; Briganti A; Montorsi F; Stenzl A; Stief C; Tombal B; Van Poppel H; Touijer K
Eur Urol; 2015 May; 67(5):839-49. PubMed ID: 24698524
[TBL] [Abstract][Full Text] [Related]
16. Early Detection of Prostate Cancer: AUA/SUO Guideline Part I: Prostate Cancer Screening.
Wei JT; Barocas D; Carlsson S; Coakley F; Eggener S; Etzioni R; Fine SW; Han M; Kim SK; Kirkby E; Konety BR; Miner M; Moses K; Nissenberg MG; Pinto PA; Salami SS; Souter L; Thompson IM; Lin DW
J Urol; 2023 Jul; 210(1):46-53. PubMed ID: 37096582
[TBL] [Abstract][Full Text] [Related]
17. Assessing the Optimal Timing for Early Salvage Radiation Therapy in Patients with Prostate-specific Antigen Rise After Radical Prostatectomy.
Fossati N; Karnes RJ; Cozzarini C; Fiorino C; Gandaglia G; Joniau S; Boorjian SA; Goldner G; Hinkelbein W; Haustermans K; Tombal B; Shariat S; Karakiewicz PI; Montorsi F; Van Poppel H; Wiegel T; Briganti A
Eur Urol; 2016 Apr; 69(4):728-733. PubMed ID: 26497924
[TBL] [Abstract][Full Text] [Related]
18. Salvage radiotherapy for biochemical and clinical failures following radical prostatectomy.
Do T; Parker RG; Do C; Tran L; Do L; Dolkar D
Cancer J Sci Am; 1998; 4(5):324-30. PubMed ID: 9815297
[TBL] [Abstract][Full Text] [Related]
19. Long-term oncologic results of salvage radical prostatectomy for locally recurrent prostate cancer after radiotherapy.
Bianco FJ; Scardino PT; Stephenson AJ; Diblasio CJ; Fearn PA; Eastham JA
Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):448-53. PubMed ID: 15890586
[TBL] [Abstract][Full Text] [Related]
20. Is the Toxicity of Salvage Prostatectomy Related to the Primary Prostate Cancer Therapy Received?
Ribeiro L; Stonier T; Stroman L; Tourinho-Barbosa R; Alghazo O; Winkler M; Dasgupta P; Popert R; Cathelineau X; Sanchez-Salas R; Murphy DG; Emberton M; Cathcart P
J Urol; 2021 Mar; 205(3):791-799. PubMed ID: 33021441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
